Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.

Journal of viral hepatitis - 1 Apr 2016

Dultz G, Gerber L, Zeuzem S, Sarrazin C, Waidmann O

Abstract excerpt

Recent data highlighted the association of the macrophage activation marker CD163 with histological inflammation and fibrosis in chronic hepatitis C virus (HCV) infection. The aim of this study was to investigate the influence of successful antiviral treatment and IL28B genotypes on macrophage activation reflected by CD163 levels in HCV infected patients. In a retrospective cohort study, serum sCD163 levels were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Differentiation, Myelomonocytic
Share to CD163 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Histocytochemistry

Share to Interferons

Share to Interleukins

Share to Macrophage Activation

Share to Receptors, Cell Surface

Source

Identifiers

PMID: 26554542
DOI: 10.1111/jvh.12488

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients.PMID 26554542Read ↗

Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and CSemantic proximity Read ↗

Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitisSemantic proximity Read ↗

The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's disease.Semantic proximity Read ↗

IL-4, IL-17 and CD163 Immunoexpression and IL-6 Gene Polymorphism in Chronic Hepatitis C Patients and Associated Hepatocellular Carcinoma.Semantic proximity Read ↗

Alterations in the hepatic microenvironment following direct-acting antiviral therapy for chronic hepatitis CSemantic proximity Read ↗

The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.Semantic proximity Read ↗

Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinomaSemantic proximity Read ↗

Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation.Semantic proximity Read ↗

Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients.Semantic proximity Read ↗

Performance of serum CD163 as a marker of fibrosis in patients with NAFLDSemantic proximity Read ↗

Macrophage Phenotypes and Hepatitis B Virus InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.